In conclusion, these data show that nonnal prepubertal growth may occur in spite of QID only after low radiation doses. They suggest that a residual low Gti secretion may paradoxically be sufficient to promote growth in some patients by an unclear mechanism. In a previous study we found that after two years or more post radiotherapy for a brain tumor (81) all children investigated had a very low spontaneous GH-secretion. The aim was now to evaluate how soon after radiotherapythis GH-impairment occurrs. For the last three years all prepubertal children (n=5) irradiated For a BT at our hospital have been studied every 6 months after irradiation with a 24h-GH profile immediately followed by a GHRH (1-29) test. Integrated 30 min samples over 24h were measured and analysed with Pulsar program.
Results: During 0,5 -2 years post irradiation GH secretion in three children irradiated with 35-40 Gy to the hypothalamus, declined progressively whereas two children who had received 56 Gy showed a blunted secretion already at the first measurement. After two years all children had a very low spontaneous GH-secretion; AUCb4100 mU/1 and CH max 4 14 mU/l. GH-response after GHRH declined gradually in each child during the two years but remained >30 mU/1. The growth rate decreased in all children.
Conclusion: This first longitudinal study performed during the first two years after irradiation for a BT supports the previous hypothesis that if GH-secretion is to be evaluated the appropriate time is at two years post irradiation. Before this time GH-secretion is heterogenous, probably due to the dose of irradiation delivered. 
ENDOCRINE DISORDERS DUE TO CRANIAL IRRADIATION
Effects of central nervous system (CNS) radiation on hypothalamic-pituitary function were studied in children with leukemia and brain tumors. Acute lym hatic leukemia (ALL): Twenty-one children in complete c G c a l P r e m i s s m e~n e d not earlier than 2 years following therapy, chronological age (CA) 10-14 yrs., CNS radiation dose 2100 rad. Results: Height SDS pretreatment +1.51, this value was significantly reduced posttreatment. -Basal and LH-RH-stimulated FSH levels were decreased in prepubertal patients and in pubertal girls. No significant differences with controls in 13, T4, TOG, basal and TRH-stimulated TSH and basal and TRH-stirnulated prolactin values. Significant decrement in basal, circadian, lysinevasopressin (LVP)-and insulin-hypoglycemia (111)-stimulated ACTH and cortisol levels. Reduced GH levels following (1H). 56 Sd1001 of Medicke. SBItiago de colpcstela. Spain.
I n o r d e r t o i n v e s t i g a t e t h e e f f e c t s~b y e x t e m a l C R m~i n e s )~, QwI3 velocity was also pericdically evaluated. Mean age at d i m i s was 4.2 years ( m e : 9 m n~ to 8 y.).
~i n p l a r m a~~m a a u P d b y s e n s i t i v e~.~( m a n + 9 ) ) . 4 children 1-17 years at the time of bone marrow transplantation BMT) have been followed regarding their endocrinological developent at yearly intervals for at least 3 years. Diagnosis leading to MT was leukemia (n.28) or severe aplastic anemia (SAA n.6).
Before MT all the patients were conditioned with cyclophosphamide and the eukemic children also had total body irradiation (TBI) 10 GY. hallenge tests with TRH, ACTH and LH-RH were given and cortisol esponse to insuline hypoglycemia was also evaluated. The children ith SAA all exhibited normal function of their thyroid, adrenal gonadal glands. The leucemic children showed some sign of thyrdysfunction in 14/28 cases. All leucemic girls (n=12) show evit signs of gonadal damage. None of them have entered into sponeous puberty and have extremely low values of oestradiol at ages n puberty should have started. Gonadotropin levels were extremehigh. The boys show more variation in their gonadal effects. 
BONE MARROW TRANSPLANTATION (BMI) FOR MALIGNANCIES.
Total body irradiation (TBI) is used in preparation for BMI and in order to evaluate the course of growth and endocrine disturbances an extensive follow-up has been designed. 17 children, aged 2.4-17.8 years received BMI for ALL (n=14), AML (n=2) and CML (n=l). Median height SDS in 14 children below age 15 was at time of BMI +0.48 (range -1.42 to 1.60) and after 12 months +0.12 (-1.16 to 1.20) (p<0.05). Those followed for 24 (ns9) and 36 months (n=6) had no significant fall in height SDS. Serum somatomedin C in the 6 cases followed for 36 months was normal. Peak growth hormone values after clonidine showed great variation and the results were inconclusive. Primary hypothyroidism was found in one case and elevated TSH values in 3 with T4 in normal range. No evidence of TSH insufficiency was seen. In all 8 girls above 10 years ovarian insufficiency developed and all were in need of replacement therapy. Of 2 boys above 10 years one had subnormal serum testosterone and one had bilateral orchi. ectomy performed. 6 of 7 boys below 10 years had normal gonadotropin response to LHRH and one was hyperresponsive. No evidence of gonadotropin insufficiency was found. Although preliminary, our data show that growth retardation does not seem to be of major importance whereas gonadal deficiency is pronounced and thyroid deficiency may be frequent. More data are needed and a detailed and prolonged endocrine follow-up seems essential.
